Cardinal Health (CAH) is back on investors’ radar after fresh company data highlighted revenue of about US$234.3b and net ...

Cardinal Health, Inc. (NYSE:CAH) is one of the stocks Jim Cramer discussed, along with market shortages. Mentioning that they like the company, a caller asked for Cramer’s take on it, and he replied: ...

The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

New NAHR Fellow and retiring CHRO Ola Snow of Cardinal Health says investment in culture has been critical to the ...

Cardinal Health stock reached an all-time high of $215.54, marking a significant milestone for the $50.7 billion healthcare company. Over the past year, Cardinal Health has experienced a remarkable 66 ...

Cardinal Health has updated its financial outlook for fiscal year 2026 non-GAAP diluted earnings per share (EPS) to at least ...

Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to ...

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Trump administration's tariffs ...

Adds over 750 providers to Cardinal Health's (CAH) multi-specialty MSO platform, The Specialty Alliance Joins with recent urology acquisitions to bolster The Specialty Alliance's leadership in the ...